Patents by Inventor Haihong Zhong

Haihong Zhong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240101717
    Abstract: This application provides novel bispecific antigen-binding antibodies, and antigen-binding fragments thereof, that bind to both HER2 and Trop-2. These bispecific anti-HER2/Trop-2 antibodies comprise a first antigen-binding domain that specifically binds human HER2 or Trop-2, and a second antigen-binding domain that specifically binds human Trop-2 or HER2. The bispecific antibodies have high binding affinity for HER2 and Trop-2, can be internalized by cells expressing HER2 and/or Trop-2. The bispecific antibody-drug conjugates (ADC) are capable of inhibiting the growth of tumors cells expressing HER2 and/or Trop-2 in vitro and in vivo. The bispecific antibodies can be used to diagnose, prognose, and treat HER2- and/or Trop-2-associated human diseases (e.g., cancer, infectious diseases, autoimmune diseases, asthma, transplant rejection, and inflammatory disorders).
    Type: Application
    Filed: January 24, 2022
    Publication date: March 28, 2024
    Inventors: Haifeng BAO, Haihong ZHONG, Wei YUAN, Dingguo LIU
  • Publication number: 20160324962
    Abstract: The present invention provides compositions and methods for the treatment of sarcoma. The compositions comprise an antibody that binds at least one of IGF-1 and IGF-2 and an mTOR inhibitor. The mTOR inhibitor may be AZD2014 or rapamycin.
    Type: Application
    Filed: December 17, 2014
    Publication date: November 10, 2016
    Inventor: HAIHONG ZHONG
  • Publication number: 20140302055
    Abstract: Antibodies directed to the antigen ANGPTL4 and uses of such antibodies. In accordance with the teachings herein, there are provided fully human monoclonal antibodies directed to the antigen ANGPTL4. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.
    Type: Application
    Filed: October 15, 2012
    Publication date: October 9, 2014
    Inventors: Haihong Zhong, Qing Zhou
  • Publication number: 20070098715
    Abstract: The invention described herein relates to antibodies directed to the antigen Ten-M2 and uses of such antibodies. In particular, there are provided fully human monoclonal antibodies directed to the antigen Ten-M2. Isolated polynucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR's) and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.
    Type: Application
    Filed: March 27, 2006
    Publication date: May 3, 2007
    Inventors: Seth Ettenberg, Stephanie Masterman, William LaRochelle, Haihong Zhong
  • Patent number: 7141549
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Grant
    Filed: February 8, 2005
    Date of Patent: November 28, 2006
    Inventors: Peter Mezes, Luca Rastelli, John Herrmann, John MacDougall, Haihong Zhong, Stacie Casman, Ferenc Boldog, Richard Shimkets, Linda Gorman, Andrew Eisen, Steven Spaderna, Corine Vernet, Constance Berghs, Kimberly Spytek, Vincent DiPippo, Bryan Zerhusen, John Peyman, Karen Ellerman, David Stone, William Grosse, John Alsobrook, II, Denise Lepley, Daniel Rieger, Catherine Burgess, Shlomit Edinger, Edward Voss, Charles Miller
  • Publication number: 20060211031
    Abstract: The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: April 6, 2006
    Publication date: September 21, 2006
    Inventors: Haihong Zhong, William LaRochelle, Suresh Shenoy, Nikolai Khramtsov
  • Publication number: 20060084054
    Abstract: The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: June 4, 2003
    Publication date: April 20, 2006
    Inventors: John Alsobrook, David Anderson, Jason Baumgartner, Constance Berghs, Ferenc Boldog, Catherine Burgess, Stacie Casman, Elina Catterton, Mohanraj Dhanabal, Shlomit Edinger, Karen Ellerman, Seth Ettenberg, Esha Gangolli, Valerie Gerlach, Linda Gorman, William Grosse, Erik Gunther, Xiaojia Guo, Vladimir Gusev, John Herrmann, Weizhen Ji, Ramesh Kekuda, Nikolai Khramtsov, William LaRochelle, Li Li, Hongping Liang, Kenneth Low, John MacDougall, Timothy Maclachlan, Uriel Malyankar, Kelly McQueeney, Amanda Mezick, Charles Miller, Isabelle Millet, Muralidhara Padigaru, Meera Patturajan, John Peyman, Xiaozhong Qian, Luca Rastelli, Daniel Rieger, Mark Rothenberg, Suresh Shenoy, Richard Shimkets, Glennda Smithson, Kimberly Spytek, David Stone, Sujatha Sukumaran, Edward Szekeres, Corine Vernet, Edward Voss, Adam Wolenc, Mei Zhong, Haihong Zhong
  • Patent number: 6991901
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Grant
    Filed: January 11, 2002
    Date of Patent: January 31, 2006
    Assignee: Curagen Corporation
    Inventors: Luca Rastelli, John L. Herrmann, John R. MacDougall, Haihong Zhong
  • Publication number: 20060013813
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: February 8, 2005
    Publication date: January 19, 2006
    Inventors: Peter Mezes, Luca Rastelli, John Herrmann, John MacDougall, Haihong Zhong, Stacie Casman, Frenc Boldog, Richard Shimkets, Linda Gorman, Andrew Eisen, Steven Spaderna, Corine Vernet, Constance Berghs, Kimberly Spytek, Vincent DiPippo, Bryan Zerhusen, John Peyman, Karen Ellerman, David Stone, William Grosse, John Alsobrook, Denise Lepley, Daniel Rieger, Catherine Burgess, Sholmit Edinger, Edward Voss, Charles Miller
  • Patent number: 6964849
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: November 15, 2005
    Assignee: Curagen Corporation
    Inventors: Luca Rastelli, John L. Herrmann, John R. MacDougall, Haihong Zhong
  • Publication number: 20050142137
    Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against secretory leukocyte protease inhibitor (SLPI) and antigen binding fragments thereof. Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules are provided. The invention provides antibodies and antigen-binding fragments thereof specifically bind to SLPI; act to neutralize SLPI activity; and can modulate SLPI effects.
    Type: Application
    Filed: November 8, 2004
    Publication date: June 30, 2005
    Applicant: CuraGen Corporation
    Inventors: Michael Gallo, Daniel Chui, Haihong Zhong, Gulshan Ara, William LaRochelle
  • Publication number: 20040043382
    Abstract: The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases.
    Type: Application
    Filed: March 7, 2002
    Publication date: March 4, 2004
    Inventors: Muralidhara Padigaru, Kimberly A. Spytek, Suresh G. Shenoy, Raymond J. Taupier, Carol E. A. Pena, Li Li, Bryan D. Zerhusen, Vladimir Y. Gusev, Weizhen Ji, Linda Gorman, Charles E. Miller, Ramesh Kekuda, Meera Patturajan, Esha A. Gangolli, Corine A.M. Vernet, Xiaojia Sasha Guo, Velizar T. Tchernev, Elma R. Fernandes, Stacie J. Casman, Uriel M. Malyankar, Valerie Gerlach, Yi Liu, David W. Anderson, Steven K. Spaderna, Elina Catterton, Mario W. Leite, Haihong Zhong, John P. Alsobrook, Denise M. Lepley, Daniel K. Rieger, Catherine E. Burgess
  • Publication number: 20040033491
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: December 10, 2001
    Publication date: February 19, 2004
    Inventors: John P. Alsobrook, David W. Anderson, Catherine E. Burgess, Ferenc L. Boldog, Stacie J. Casman, Steven D. Colman, Shlomit R. Edinger, Karen Ellerman, Valerie Gerlach, Linda Gorman, William M. Grosse, Xiaojia Sasha Guo, John L. Herrmann, Ramesh Kekuda, Denise M. Lepley, Li Li, John R. MacDougall, Isabelle Millet, Carol E. A. Pena, John A. Peyman, Luca Rastelli, Daniel K. Rieger, Richard A. Shimkets, Glennda Smithson, Kimberly A. Spytek, David J. Stone, Velizar T. Tchernev, Corine A.M. Vernet, Edward Z. Voss, Bryan D. Zerhusen, Haihong Zhong, Mei Zhong
  • Publication number: 20040023259
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: February 12, 2003
    Publication date: February 5, 2004
    Inventors: Luca Rastelli, Haihong Zhong, Ferenc L. Boldog, Esha A. Gangolli, Xiaojia (Sasha) Guo, Uriel M. Malyankar, Meera Patturajan, Carol E. A. Pena, Richard A. Shimkets, Kimberly A. Spytek, Corine A. M. Vernet, Daniel K. Rieger, Shlomit R. Edinger, Catherine E. Burgess
  • Publication number: 20040023241
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: December 2, 2002
    Publication date: February 5, 2004
    Inventors: John P. Alsobrook, David W. Anderson, Ferenc L. Boldog, Catherine E. Burgess, Rajeev A. Chillakuru, Shlomit R. Edinger, Valerie Gerlach, Linda Gorman, Bonnie Gould-Rothberg, Xiaojia Sasha Guo, Michael E. Jeffers, Weizhen Ji, Li Li, Uriel M. Malyankar, Charles E. Miller, Ryan Murphey, Meera Patturajan, John A. Peyman, Luca Rastelli, Daniel K. Rieger, Suresh G. Shenoy, Glennda Smithson, Gary Starling, Raymond J. Taupier, Edward Z. Voss, Haihong Zhong, Mei Zhong
  • Publication number: 20040018196
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: January 11, 2002
    Publication date: January 29, 2004
    Inventors: Peter D. Mezes, Luca Rastelli, John L. Herrmann, John R. MacDougall, Haihong Zhong, Stacie J. Casman, Ferenc L. Boldog, Richard A. Shimkets, Linda Gorman, Andrew J. Eisen, Steven K. Spaderna, Corine A.M. Vernet, Constance Berghs, Kimberly A. Spytek, Vincent A. DiPippo, Bryan D. Zerhusen, John A. Peyman, Karen Ellerman, David J. Stone, William M. Grosse, John P. Alsobrook, Denise M. Lepley, Daniel K. Rieger, Catherine E. Burgess, Shlomit R. Edinger
  • Publication number: 20040014058
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: October 1, 2002
    Publication date: January 22, 2004
    Inventors: John P. Alsobrook, Catherine E. Burgess, Elina Catterton, John S. Chant, Ammitabha Chaudhuri, Shlomit Edinger, Valerie Gerlach, Loic Giot, Linda Gorman, Xiaojia (Sasha) Guo, Ramesh Kekuda, Peter S. Mezes, Isabelle Millet, Chean Eng Ooi, Meera Patturajan, Daniel K. Rieger, Kimberly A. Spytek, Raymond J. Taupier, Bryan D. Zerhusen, Haihong Zhong, Mei Zhong
  • Publication number: 20040006205
    Abstract: Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: April 2, 2002
    Publication date: January 8, 2004
    Inventors: Li Li, Valerie Gerlach, Xiaohong Liu, Charles E. Miller, Kimberly A. Spytek, Bryan D. Zerhusen, Carol E. A. Pena, Suresh G. Shenoy, Haihong Zhong, Glennda Smithson, Stacie J. Casman, Ferenc L. Boldog, Edward Z. Voss, Corine A. Vernet, John R. MacDougall, Luca Rastelli, David W. Anderson, Mei Zhong, Peter S. Mezes, Katarzyna Furtak, Meera Patturajan, Catherine E. Burgess, Uriel M. Malyankar, Richard A. Shimkets, Raymond J. Taupier, Schlomit Edinger, Ann Mazur
  • Publication number: 20030215449
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: March 15, 2002
    Publication date: November 20, 2003
    Inventors: Peter D. Mezes, Luca Rastelli, John L. Herrmann, John R. MacDougall, Haihong Zhong, Stacie J. Casman, Ferenc L. Boldog, Richard A. Shimkets, Linda Gorman, Andrew J. Eisen, Steven K. Spaderna, Corine A.M. Vernet, Constance Berghs, Kimberly A. Spytek, Vincent A. DiPippo, Bryan D. Zerhusen, John A. Peyman, Karen Ellerman, David J. Stone, William M. Grosse, John P. Alsobrook, Denise M. Lepley, Daniel K. Rieger, Catherine E. Burgess, Shlomit R. Edinger, Edward Z. Voss, Charles E. Miller
  • Publication number: 20030198955
    Abstract: Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: December 19, 2001
    Publication date: October 23, 2003
    Inventors: Li Li, Muralidhara Padigaru, Robert A. Ballinger, Ramesh Kekuda, Steven D. Colman, Kimberly A. Spytek, Stacie J. Casman, Shlomit R. Edinger, Valerie Gerlach, Paul Sciore, Glennda Smithson, John A. Peyman, John R. MacDougall, David J. Stone, Corine A.M. Vernet, Suresh G. Shenoy, Erik Gunther, Isabelle Millet, Velizar T. Tchernev, David W. Anderson, Vladimir Y. Gusev, Uriel M. Malyankar, Haihong Zhong, Karen Ellerman, Adam R. Wolenc